Literature DB >> 14695544

First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant.

Christelle Cauffiez1, Jean-Marc Lo-Guidice, Dany Chevalier, Delphine Allorge, Rima Hamdan, Michel Lhermitte, Jean-Jacques Lafitte, Jean-Frédéric Colombel, Christian Libersa, Franck Broly.   

Abstract

In the present study, we report the first investigation of polymorphisms in the human CYP3A43 gene. A screening for sequence variations in the 5'-flanking and protein coding regions of the CYP3A43 gene was performed by a Polymerase Chain Reaction - Single Strand Conformational Polymorphism (PCR-SSCP) strategy, using DNA samples from 48 unrelated French individuals. Three polymorphisms in the coding region were identified, comprising two nucleotide substitutions, one silent (c.1047C>T) and one missense mutation (c.1018C>G/P340A), and a frame shift mutation (c.74delA), leading to a premature stop codon and, presumably, to a severely truncated protein. In order to evaluate the extent of the frame shift mutation in a larger population, 352 individuals were further genotyped. Thirty-four samples (4.83%) were found to be heterozygous and one homozygous (0.14%) for the nucleotide deletion, which suggests that, although the potential significance of this polymorphism remains to be further evaluated, some individuals are deficient for CYP3A43 activity. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695544     DOI: 10.1002/humu.9211

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  4 in total

Review 1.  Significance of the minor cytochrome P450 3A isoforms.

Authors:  Ann K Daly
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors:  Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

Review 3.  Genetic variation in CYP3A43 is associated with response to antipsychotic medication.

Authors:  Eva J Brandl; Nabilah I Chowdhury; Arun K Tiwari; Tristram A P Lett; Herbert Y Meltzer; James L Kennedy; Daniel J Müller
Journal:  J Neural Transm (Vienna)       Date:  2014-08-24       Impact factor: 3.575

4.  Joint effects of inflammation and androgen metabolism on prostate cancer severity.

Authors:  Timothy R Rebbeck; Hanna Rennert; Amy H Walker; Saarene Panossian; Teo Tran; Kyle Walker; Elaine Spangler; Margerie Patacsil-Coomes; Rajeev Sachdeva; Alan J Wein; S Bruce Malkowicz; Charnita Zeigler-Johnson
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.